Pierosandro Tagliaferri

Author

Magna Graecia University ORCID

Also Known As

Massimo Gentile, P TAGLIAFERRI, P Tagliaferri, P. TAGLIAFERRI, P. Tagliaferri, Pierosandro Tagliaferri

172

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Magna Graecia University Temple University University of Milan University of Naples Federico II Dana-Farber Cancer Institute

About

Pierosandro Tagliaferri is an author at Magna Graecia University specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	895
2	Cell Biology	13	15	658
3	Engineering	3	3	60
4	Health Sciences	2	2	52
5	Biostatistics	1	1	25

Pierosandro Tagliaferri

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <i>In Vitro</i> and <i>In Vivo</i> Evidence Maria Teresa Di Martino, Emanuela Leone, Nicola Amodio, Clinical Cancer Research	2012	243
Targeting miR-21 Inhibits <i>In Vitro</i> and <i>In Vivo</i> Multiple Myeloma Cell Growth Emanuela Leone, Eugenio Morelli, Maria Teresa Di Martino, Clinical Cancer Research	2013	213
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 Nicola Amodio, Maria Teresa Di Martino, Umberto Foresta, Cell Death and Disease	2012	159
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Oncotarget	2013	140
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines Pierfrancesco Tassone, Stefania Forciniti, Eulalia Galea, Leukemia Synergistic InductionMedicineApoptosisGrowth InhibitionCell Death	2000	138
Current approaches and perspectives in the therapy of medullary thyroid carcinoma Giovanni Vitale, Michele Caraglia, Antonio Ciccarelli, Cancer	2001	126
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio, Leukemia	2015	122
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Clinical Cancer Research	2015	118
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, PLoS ONE	2014	115
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma Annamaria Gullà, Teru Hideshima, Giada Bianchi, Leukemia Hematological MalignancyDruggable TargetMedicinePrognostic RelevanceImmunology	2017	97

Page 1